Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab Publisher Pubmed

Moghadasi AN^{1, 2} ; Baghbanian SM³

Show Affiliations

1. MS Research Centre, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Sina Hospital, Tehran University of Medical Sciences, Hasan Abad Square, Tehran, 11367-46911, Iran
3. Neurology Department, Booalisina Hospital, Mazandaran University of Medical Sciences, Pasdaran Boulevard, Sari, Iran

Source: Acta Neurologica Belgica Published:2019

[No abstract available]

Style	Citing Format
MLA	Moghadasi AN, Baghbanian SM. "Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab." Acta Neurologica Belgica, vol. 119, no. 1, 2019, pp. 137-139.
APA	Moghadasi AN, Baghbanian SM (2019). Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab. Acta Neurologica Belgica, 119(1), 137-139.
Chicago	Moghadasi AN, Baghbanian SM. "Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab." Acta Neurologica Belgica 119, no. 1 (2019): 137-139.
Harvard	Moghadasi AN, Baghbanian SM (2019) 'Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab', Acta Neurologica Belgica, 119(1), pp. 137-139.
Vancouver	Moghadasi AN, Baghbanian SM. Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab. Acta Neurologica Belgica. 2019;119(1):137-139.
BibTex	@article{ author = {Moghadasi AN and Baghbanian SM}, title = {Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab}, journal = {Acta Neurologica Belgica}, volume = {119}, number = {1}, pages = {137-139}, year = {2019} }
RIS	TY - JOUR AU - Moghadasi AN AU - Baghbanian SM TI - Tumefactive Demyelinating Lesions in a Patient With Multiple Sclerosis Receiving Natalizumab JO - Acta Neurologica Belgica VL - 119 IS - 1 SP - 137 EP - 139 PY - 2019 ER -